Cell therapy breakthroughs in cancer treatment

The Translational Research Unit at the Section for Cellular Therapy based in Norway recently published two groundbreaking studies showcasing the potential of cell-based therapies in combating cancer.

Lytix and Curida: Growth and innovation

Lytix Biopharma and Curida, both Norwegian-owned, have gained attention and acclaim for their innovative approaches and substantial contributions to the healthcare sector.

Sammen om superklynge

De fire helseklyngene gikk denne uka sammen om et høringsinnspill til Stortinget.

Har partiene en kreftpolitikk?

During the breakfast seminar The Future of Cancer Politics four politicians discussed possible health- and cancer policies in their coming party programmes. The seminar was held in Norwegian.